352 related articles for article (PubMed ID: 23065508)
1. Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant.
McIver Z; Melenhorst JJ; Wu C; Grim A; Ito S; Cho I; Hensel N; Battiwalla M; Barrett AJ
Haematologica; 2013 Mar; 98(3):346-52. PubMed ID: 23065508
[TBL] [Abstract][Full Text] [Related]
2. Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation.
Melenhorst JJ; Tian X; Xu D; Sandler NG; Scheinberg P; Biancotto A; Scheinberg P; McCoy JP; Hensel NF; McIver Z; Douek DC; Barrett AJ
Haematologica; 2012 Jun; 97(6):867-73. PubMed ID: 22133778
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Anandi P; Tian X; Ito S; Muranski P; Chokshi PD; Watters N; Chawla U; Hensel N; Stroncek DF; Battiwalla M; Barrett AJ
Cytotherapy; 2017 Jun; 19(6):735-743. PubMed ID: 28395942
[TBL] [Abstract][Full Text] [Related]
5. The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Clin Transplant; 2019 Jun; 33(6):e13537. PubMed ID: 30873642
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
8. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.
Clave E; Busson M; Douay C; Peffault de Latour R; Berrou J; Rabian C; Carmagnat M; Rocha V; Charron D; Socié G; Toubert A
Blood; 2009 Jun; 113(25):6477-84. PubMed ID: 19258596
[TBL] [Abstract][Full Text] [Related]
9. Altered thymic CD4
Roussel X; Daguindau E; Berceanu A; Desbrosses Y; Saas P; Ferrand C; Seilles E; Pouthier F; Deconinck E; Larosa F
Curr Res Transl Med; 2019 Nov; 67(4):135-143. PubMed ID: 31164285
[TBL] [Abstract][Full Text] [Related]
10. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.
Kanda J; Chiou LW; Szabolcs P; Sempowski GD; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McPherson J; Hale J; Livingston JA; Broadwater G; Niedzwiecki D; Chao NJ; Horwitz ME
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1664-1676.e1. PubMed ID: 22698485
[TBL] [Abstract][Full Text] [Related]
11. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
[TBL] [Abstract][Full Text] [Related]
12. The helper T lymphocyte precursor (HTLp) frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilised peripheral blood stem cell transplantation.
Healey G; Schwarer AP
Bone Marrow Transplant; 2002 Sep; 30(6):341-6. PubMed ID: 12235517
[TBL] [Abstract][Full Text] [Related]
13. Association between thymic function and allogeneic hematopoietic stem cell transplantation outcome: results of a pediatric study.
Saglio F; Cena S; Berger M; Quarello P; Boccasavia V; Ferrando F; Pittana L; Bruno B; Fagioli F
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1099-105. PubMed ID: 25708218
[TBL] [Abstract][Full Text] [Related]
14. Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.
Konuma T; Kato S; Oiwa-Monna M; Ishii H; Tojo A; Takahashi S
Leuk Lymphoma; 2016 Sep; 57(9):2126-32. PubMed ID: 26769297
[TBL] [Abstract][Full Text] [Related]
15. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M
Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638
[TBL] [Abstract][Full Text] [Related]
18. T-Cell recovery in adults and children following umbilical cord blood transplantation.
Klein AK; Patel DD; Gooding ME; Sempowski GD; Chen BJ; Liu C; Kurtzberg J; Haynes BF; Chao NJ
Biol Blood Marrow Transplant; 2001; 7(8):454-66. PubMed ID: 11569891
[TBL] [Abstract][Full Text] [Related]
19. [IL-18 single nucleotide polymorphisms in hematologic malignancies with HLA matched sibling donor allogeneic hematopoietic stem cell transplantation].
Cai X; Song A; Wang H; Zhang P; Zhang G; Yang F; Wei J; Ma Q; Yan Z; Jiang E; Huang Y; Yang D; Wang M; He Y; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):215-20. PubMed ID: 24666487
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
Xiao H; Luo Y; Lai X; Fu S; Shi J; Tan Y; He J; Xie W; Zheng W; Wang LM; Zhang L; Liu L; Ye X; Yu X; Cai Z; Lin M; Huang H
Haematologica; 2012 Dec; 97(12):1804-12. PubMed ID: 22733023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
